Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00000010
DRKS00000010
Completed
Not Applicable

Body compositional and endocrine-metabolic changes by long-term lifestyle intervention with health education, diet (Almased®), physical activity or a combination of diet and physical activity in obese persons

niversitätsklinikum Freiburg0 sites114 target enrollmentSeptember 5, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDietoverweightE66.0Obesity due to excess calories

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dietoverweight
Sponsor
niversitätsklinikum Freiburg
Enrollment
114
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 5, 2008
End Date
December 1, 2002
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Eligible participants must have overweight with a BMI between 27,5 and 35 kg/m²
  • •\- The participants must be able to participate in a physical activity program
  • •\- The participants must be willing to participate in the program for 1 year
  • •\- Written informed consent must be given to accept randomization to either of the intervention groups

Exclusion Criteria

  • •\- Participants who do not meet all entry criteria
  • •\- BMI \> 35,0 kg / m²
  • •\- Performance capacity \< 75 w for 2 min
  • •\- Subjects younger than 35 yrs (with reference age at 1st Jan 2002: 34\.5 yrs) or older than 65 yrs (with reference age at 1st 2002: 65\.5 yrs)
  • •\- Absolute or relative contraindications to exercise testing of the ACSM
  • •\- Persons unable or with restrictions to participate in a regular physical activity program because of any disease (e.g. history of CHD, arrhythmia, valvular heart disease, arthritis of major joints)
  • •\- Severe hypertension systolic BP of \> 200 mm Hg and or diastolic BP of \> 105 mm Hg at rest
  • •\- Persons with established insulin dependent diabetes mellitus (IDDM)
  • •\- Persons with a disease of the liver or the kidneys prohibiting high protein intake
  • •\- Persons with a disease of the thyroid gland or taking thyroid hormones

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
se of insulin sensitisers to revert metabolic syndrome
ISRCTN58810841Hospital Sant Joan de Deu (Spain)52
Active, not recruiting
Phase 1
Changes in weight, body composition and metabolic parameters in HIV infected patients after switch from 2- to 3-drug treatment
EUCTR2020-000205-89-DKDepartment of Infectious Diseases, Hvidovre Hospital126
Active, not recruiting
Phase 1
Changes in weight, body composition and metabolic parameters in HIV infected patients after switched treatment
EUCTR2019-004999-19-DKDepartment of infectious diseases, Hvidovre Hospital95
Not yet recruiting
Not Applicable
Changes in body composition, dietary intake, and physical activity in children with cancer - a master protocolGewichtsstoornissenbody compositionNutritional status1000301810027655
NL-OMON56855Prinses Máxima Centrum voor Kinderoncologie500
Active, not recruiting
Not Applicable
Effects on Endocrine-Metabolic Parameters and Body Composition of the Addition of Low-Dose Pioglitazone to Flutamide-Metformin Therapy in Young Women with Hyperinsulinemic Ovarian Hyperandrogenism and Cardiovascular Risk - Pioglitazone in PCOSPolycystic Ovary Syndrome includes anovulatory hyperandrogenism, hyperinsulinemia and/or dyslipidemia. Adiponectin and interleukin-6 are adipocytokines that have been related to abdominal fat excess and/or impaired insulin sensitivity. These cytokines -together with other indices of low-grade inflammation-, sucj as C-reactive protein (CRP), and the neutrophil count, contribute to link insulin-resistant states with cardiovascular disease risks.
EUCTR2005-004163-39-ESHospital Sant Joan de Déu40